A NASA technology originally developed for the space program has evolved into a state-of-the-art medical device that increases the effectiveness of chemotherapy treatments and provides natural, drug-free pain relief for thousands of Americans.
I’ve said it before, and I’ll say it again: You have to be patient when it comes to technology licensing—especially if you’re talking about commercialization of an innovation for medical use. Yesterday, in conjunction with Breast Cancer Awareness Month, NASA’s Goddard...
As any parent knows, it can be a challenge for young children to sit still during an eye exam, let alone respond to a series of questions about what they are seeing. In the case of infants and pre-verbal children, the challenges are nearly insurmountable. And yet,...
Metrics are one of the most challenging aspects of licensing that any technology transfer office (TTO) faces when pursuing commercialization of intellectual property. And yet they’re one of the most important.
Editor’s note: This is the fifth in a six-post series on how Fuentek views technology licensing through a new PRISM. Many people cite Winston Churchill as saying that “Consistency is the hobgoblin of little minds.” But there is a key word they’re leaving out of that...
Get useful tech transfer tips and news delivered right to your inbox!
By submitting this form, you are consenting to receive emails from: Fuentek, LLC. You can unsubscribe at any time by clicking the link at the bottom of every email.
